Member Info for Wildforce

Trades of that size are unusual at scancell .. the only thing we really know is , they came from somewhere and they went somewhere else ! Been a few sizeable black trades recently but that’s by far the largest one eh !

Take care all !

Phil does mention partnering a few times in his most recent statement ..

“We continue our partnering discussions on iSCIB1+ and the ImmunoBody® platform with the regulatory feedback in hand and will evaluate all financing options with the dual focus on progressing the Phase 3 trial in a timely manner and optimising shareholder value. There is continuing partnering interest in our lead antibody, SC134, and our other GlyMab® candidates through which we expect to generate further shareholder value in the coming year, while we will also explore partnering opportunities for Moditope® following new Modi-1 Phase 2 data expected in H1 2026."

Whilst there is no mention of who , I’d imagine it wouldn’t just be one ??

Take care all ..

Hi Chester,

It’s not a secret I’m not a trader .. just been buying the dips for many years .. I have a good chunk now all in stocks and shares ISA and its value varies wildly week to week ! lol .. I’m letting the board do the valuing of my holding as I think for a phase 3 biotech 13p just makes me chuckle !

Only my opinion of course as ever ! Do not take any of my words as advice lol !

Take care ..

Late reported 500k buy there .. fascinating phase of trading going on !

Take care all ..

Just noticed another chunky delayed buy from yesterday !

Take care all ..

Evening Rats .. looks like the usual ‘sell on news’ habit has fed some waiting to add or get in !?

Oh and thanks berm/cleaner for your earlier comments ! Been a very tough couple of years personally. Always kept an eye on here .. still miss C7s comments .. he was certainly a character.

Fingers crossed for scancell and its continued journey to …… fruition , whatever that looks like!

Take care all ..

Time to dig out Keith Flaherty’s number again!?

Thanks Berm, they have done it all before .. just need to scale it all up.

Take care all ..

Hi Cleaner ! Interesting comments from Phil ! Liking his confidence ! I get the sense he knows things he can’t disclose in full just yet !??

Very exciting time at scancell, although you wouldn’t notice from the market !?

Take care ..

Let’s see what after market trades there are today !

Take care all ..

Interesting what’s going on in the background. Late reported trades again , eclipsing the size of anything during ‘trading hours’ ..

This is not a normal occurrence for this share over the years ?

Take care all ..

I’m certainly getting closer to being an antique lol !

Take care ..

Feels like scancell is like a Rembrandt at a car boot sale .. a sleeper ..

Take care all ..

For a bit of fun I asked google for the average value of a phase 3 immunotherapy asset … this was the answer ..

“Based on recent industry data, a Phase 3 immunotherapy asset often commands a very high valuation, frequently reaching into the hundreds of millions to over $1 billion, particularly in oncology, due to the high probability of success, the large market for checkpoint inhibitors, and potential for combination therapies. “

Interesting !?

Take care all ..

For those who can’t be bothered to sift through the report here is the bit on CVLP.

Case study: Personalised

Cancer Vaccines:

accelerating recruitment

and delivery of trials.

Personalised cancer vaccines are a form

of immunotherapy treatment tailored to

each person’s cancer, based on the

genetic changes unique to each tumour.

The UK has established global leadership

in research into cancer vaccines through

the Cancer Vaccine Launch Pad (CVLP)

and the Vaccine Innovation Pathway

(VIP). The CVLP provides an extended

network of referral sites across parts of

the country, to broaden trial access and

to streamline processing and analysis of

cancer biopsies for genetic analysis. The

VIP provides the systems and processes

to optimise trial set up and patient

recruitment. As a result of these

innovations, the UK was the fastest-

recruiting country for the first international

trial of personalised vaccination after

surgery for colorectal cancer, and is at

the forefront of trials in melanoma, head

and neck cancer and pancreatic cancer.

This has led to multi-million pound

investments in vaccine research in the UK

by the companies developing these

technologies and a rapidly-expanding

portfolio of new trials.

Take care ..

Wonder if they are aware of Scancells ‘non personalised’ results … takes 30 days to create each individuals vaccine from a biopsy ! Scancells is off the shelf.

Great thing is though , they seem pretty excited about their data … so no wonder scancell are extremely excited about theirs !

Cleaner- the cancer vaccine launch pad is in that report but it to seems to be linked to personalised treatment! When is everyone going to get that scancells isn’t a ‘personalised’ treatment !

Take care all ..

Not sure where that ‘ing’ came from lol ..

They have a vested interesting in keeping the ‘cutting edge’ technology they are aware of fully British ?

But I totally understand your thoughts.

Take care ..

“Our plan will invest billions in cutting-edge technology, new treatments and faster diagnosis. By taking advantage of the scientific revolution taking place before our eyes, we can transform the life chances for cancer patients.”

You never know .. a few quid might come scancells way ??

Take care all ..

Little reminder from last April about the governments direction .

https://www.england.nhs.uk/2025/04/skin-cancer-patients-fast-tracked-access-revolutionary-nhs-cancer-vaccine-trial/

Will be interesting to hear what tomorrow’s statement will contain ?

Take care all ..

Certainly is a fascinating situation. Those at the table will know full well the cost of a registrational phase 3 trial .. they will also know the value of success. With Scancells knowledge, contacts, results to date, and plans for the phase 3 in place … what is it Scancell need ? The money ? … there is plenty out there in the biotech and pharma arena but there arnt many scancells.

I’d say the Hook is baited … let’s see what happens but my opinion is I’d take some more dilution to keep hold of as much of the IP as possible.

Good luck to us all .. take care !